These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 18203317)
1. Polymorphisms in COL15 gene are not associated with systemic sclerosis. Pushpakom SP; Herrick AL; Kumar S; Worthington J J Rheumatol; 2008 Feb; 35(2):251-3. PubMed ID: 18203317 [TBL] [Abstract][Full Text] [Related]
2. Single-nucleotide polymorphisms in CCL2 gene are not associated with susceptibility to systemic sclerosis. Carulli MT; Spagnolo P; Fonseca C; Welsh KI; duBois RM; Black CM; Denton CP J Rheumatol; 2008 May; 35(5):839-44. PubMed ID: 18381789 [TBL] [Abstract][Full Text] [Related]
3. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population. Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Hikami K; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N Arthritis Rheum; 2009 Jun; 60(6):1845-50. PubMed ID: 19479858 [TBL] [Abstract][Full Text] [Related]
4. Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma. Zhou X; Tan FK; Reveille JD; Wallis D; Milewicz DM; Ahn C; Wang A; Arnett FC Arthritis Rheum; 2002 Nov; 46(11):2990-9. PubMed ID: 12428242 [TBL] [Abstract][Full Text] [Related]
5. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis. Liakouli V; Manetti M; Pacini A; Tolusso B; Fatini C; Toscano A; Cipriani P; Guiducci S; Bazzichi L; Codullo V; Ruocco L; Dell'orso L; Carubbi F; Marrelli A; Abbate R; Bombardieri S; Ferraccioli G; Montecucco C; Valentini G; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R Ann Rheum Dis; 2009 Apr; 68(4):584-90. PubMed ID: 18445624 [TBL] [Abstract][Full Text] [Related]
6. Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity. Dieude P; Dawidowicz K; Guedj M; Legrain Y; Wipff J; Hachulla E; Diot E; Sibilia J; Mouthon L; Cabane J; Amoura Z; Crakowski JL; Carpentier P; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y J Rheumatol; 2010 May; 37(5):987-92. PubMed ID: 20231204 [TBL] [Abstract][Full Text] [Related]
7. The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype. Rueda B; Broen J; Torres O; Simeon C; Ortego-Centeno N; Schrijvenaars MM; Vonk MC; Fonollosa V; van den Hoogen FH; Coenen MJ; Sanchez-Román J; Aguirre-Zamorano MA; García-Portales R; Pros A; Camps MT; Gonzalez-Gay MA; Martin J; Radstake TR Ann Rheum Dis; 2009 Feb; 68(2):253-6. PubMed ID: 18713787 [TBL] [Abstract][Full Text] [Related]
8. Association between a CTGF gene polymorphism and systemic sclerosis in a French population. Granel B; Argiro L; Hachulla E; Fajardy I; Weiller PJ; Durand JM; Frances Y; Dombey AM; Marquet S; Lesavre N; Disdier P; Bernard F; Hatron PY; Chevillard C J Rheumatol; 2010 Feb; 37(2):351-8. PubMed ID: 20032097 [TBL] [Abstract][Full Text] [Related]
9. Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients. Beretta L; Cappiello F; Moore JH; Barili M; Greene CS; Scorza R Arthritis Rheum; 2008 Jul; 59(7):974-83. PubMed ID: 18576303 [TBL] [Abstract][Full Text] [Related]
10. Lack of association of a functionally relevant single nucleotide polymorphism of matrix metalloproteinase-1 promoter with systemic sclerosis (scleroderma). Johnson RW; Reveille JD; McNearney T; Fischbach M; Friedman AW; Ahn C; Arnett FC; Tan FK Genes Immun; 2001 Aug; 2(5):273-5. PubMed ID: 11528521 [TBL] [Abstract][Full Text] [Related]
11. Association between Thr21Met and Ser89Asn polymorphisms of the urotensin II gene and systemic sclerosis. Pehlivan Y; Gogebakan B; Oztuzcu S; Ozgen M; Cetin GY; Bayraktar R; Cengiz B; Kisacik B; Koca SS; Donmez S; Sayarlioglu M; Demiryurek AT; Onat AM J Rheumatol; 2012 Jan; 39(1):106-11. PubMed ID: 22045841 [TBL] [Abstract][Full Text] [Related]
12. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis. Dieudé P; Guedj M; Wipff J; Ruiz B; Hachulla E; Diot E; Granel B; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Amoura Z; Fajardy I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y Arthritis Rheum; 2009 Aug; 60(8):2472-9. PubMed ID: 19644887 [TBL] [Abstract][Full Text] [Related]
13. Interleukin 1alpha single-nucleotide polymorphism associated with systemic sclerosis. Hutyrová B; Lukác J; Bosák V; Buc M; du Bois R; Petrek M J Rheumatol; 2004 Jan; 31(1):81-4. PubMed ID: 14705223 [TBL] [Abstract][Full Text] [Related]
14. Association of the FAM167A-BLK region with systemic sclerosis. Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N Arthritis Rheum; 2010 Mar; 62(3):890-5. PubMed ID: 20131239 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-10 gene promoter and NFKB1 promoter insertion/deletion polymorphisms in systemic sclerosis. Salim PH; Jobim M; Bredemeier M; Chies JA; Brenol JC; Jobim LF; Xavier RM Scand J Immunol; 2013 Feb; 77(2):162-8. PubMed ID: 23237063 [TBL] [Abstract][Full Text] [Related]
16. Association of CTLA-4 gene promoter polymorphisms with systemic sclerosis in Iranian population. Almasi S; Erfani N; Mojtahedi Z; Rajaee A; Ghaderi A Genes Immun; 2006 Jul; 7(5):401-6. PubMed ID: 16775619 [TBL] [Abstract][Full Text] [Related]
17. Evidence of potential interaction of chemokine genes in susceptibility to systemic sclerosis. Lee EB; Zhao J; Kim JY; Xiong M; Song YW Arthritis Rheum; 2007 Jul; 56(7):2443-8. PubMed ID: 17599774 [TBL] [Abstract][Full Text] [Related]
18. Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population. Bossini-Castillo L; Simeon CP; Beretta L; Vonk MC; Callejas-Rubio JL; Espinosa G; Carreira P; Camps MT; Rodríguez-Rodríguez L; Rodríguez-Carballeira M; García-Hernández FJ; López-Longo FJ; Hernández-Hernández V; Sáez-Comet L; Egurbide MV; Hesselstrand R; Nordin A; Hoffmann-Vold AM; Vanthuyne M; Smith V; De Langhe E; Kreuter A; Riemekasten G; Witte T; Hunzelmann N; Voskuyl AE; Schuerwegh AJ; Lunardi C; Airó P; Scorza R; Shiels P; van Laar JM; Fonseca C; Denton C; Herrick A; Worthington J; Koeleman BP; Rueda B; Radstake TR; Martin J; Rheumatology (Oxford); 2011 Nov; 50(11):1976-81. PubMed ID: 21875883 [TBL] [Abstract][Full Text] [Related]
19. Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis. Manetti M; Liakouli V; Fatini C; Cipriani P; Bonino C; Vettori S; Guiducci S; Montecucco C; Abbate R; Valentini G; Matucci-Cerinic M; Giacomelli R; Ibba-Manneschi L Ann Rheum Dis; 2009 Mar; 68(3):408-11. PubMed ID: 18930992 [TBL] [Abstract][Full Text] [Related]
20. A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort. Bossini-Castillo L; Broen JC; Simeon CP; Beretta L; Vonk MC; Ortego-Centeno N; Espinosa G; Carreira P; Camps MT; Navarrete N; González-Escribano MF; Vicente-Rabaneda E; Rodríguez L; Tolosa C; Román-Ivorra JA; Gómez-Gracia I; García-Hernández FJ; Castellví I; Gallego M; Fernández-Nebro A; García-Portales R; Egurbide MV; Fonollosa V; de la Peña PG; Pros A; González-Gay MA; Hesselstrand R; Riemekasten G; Witte T; Coenen MJ; Koeleman BP; Houssiau F; Smith V; de Keyser F; Westhovens R; De Langhe E; Voskuyl AE; Schuerwegh AJ; Chee MM; Madhok R; Shiels P; Fonseca C; Denton C; Claes K; Padykov L; Nordin A; Palm O; Lie BA; Airó P; Scorza R; van Laar JM; Hunzelmann N; Kreuter A; Herrick A; Worthington J; Radstake TR; Martín J; Rueda B Ann Rheum Dis; 2011 Apr; 70(4):638-41. PubMed ID: 21187296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]